Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Long-Term Debt of $202.80 million for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $202.80M | +0.1% |
| 2024 | $202.60M | +178.3% |
| 2023 | $72.80M | -64.8% |
| 2022 | $206.70M | -1.0% |
| 2021 | $208.80M | -17.4% |
| 2020 | $252.90M | -0.8% |
| 2019 | $255.00M | +30.1% |
| 2018 | $196.00M | -0.5% |
| 2017 | $197.00M | -12.9% |
| 2016 | $226.20M | -1.2% |
| 2015 | $228.90M | -25.8% |
| 2014 | $308.30M | -17.0% |
| 2013 | $371.30M | -2.0% |
| 2012 | $378.80M | +26.6% |
| 2011 | $299.30M | -16.4% |
| 2010 | $358.10M | -5.5% |
| 2009 | $379.10M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $202.70M | +0.0% | +0.0% |
| June 30, 2025 | $202.60M | +177.9% | +0.0% |
| March 31, 2025 | $202.60M | +178.3% | +0.0% |
| December 31, 2024 | $202.60M | +178.3% | +0.0% |
| September 30, 2024 | $202.60M | +33.2% | +177.9% |
| June 30, 2024 | $72.90M | -64.5% | +0.1% |
| March 31, 2024 | $72.80M | -64.7% | +0.0% |
| December 31, 2023 | $72.80M | -64.8% | -52.1% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +0.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2009–2025 period, WEST PHARMACEUTICAL SERVICES INC’s long-term debt has declined by 46.5% (from $379.10 million to $202.80 million).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: